Ovoca Bio | OVG - Operating Expenses


Ovoca Bio reported EUR173K in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 952K 60K Jun/2026
ALKERMES USD 1.86B 56.17M Sep/2026
Avita Medical AUD 28.56M 534K Jun/2026
Dianthus Therapeutics USD 62.24M 15.25M Jun/2026
Great Western Mining Corporation EUR 595.79K 109.22K Dec/2025
Ionis Pharmaceuticals USD 373M 2.76M Sep/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Malin Corporation EUR 1.1M 400K Dec/2024
Moderna USD 1.18B 223M Sep/2026
Organon & Co USD 1.19B 187M Sep/2026
Ovoca Bio EUR 173K 990K Dec/2025
Revvity USD 604.27M 719K Sep/2026
Tectonic Therapeutic USD 24.22M 3.08M Jun/2026
Viatris USD 3.49B 189.1M Sep/2026
Xeris Pharmaceuticals USD 86.93M 11.72M Jun/2026